Acorda Therapeutics Inc. v. Apotex Corp.

Application Number	Patent Number	External Links
-	US5540938	Espacenet Google Patents
-	US8007826	Espacenet Google Patents
-	US8354437	Espacenet Google Patents
-	US8440703	Espacenet Google Patents
-	US8663685	Espacenet Google Patents

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1556059.) - filed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/18/2014)

2014-07-18

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 07/18/2014)

2014-07-18

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/15/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 7/22/2017. (cla, ) (Entered: 07/18/2014)

2014-07-18

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437 B2; 8,440,703 B2; 8,663,685 B2;. (cla, ) (Entered: 07/18/2014)

2014-07-18

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alkermes plc for Alkermes Pharma Ireland Limited filed by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (cla, ) (Entered: 07/18/2014)

2014-07-18

1

View

SUMMONS Returned Executed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. Apotex Corp. served on 7/18/2014, answer due 8/8/2014. (Noreika, Maryellen) (Entered: 07/18/2014)

2014-07-18

1

View

Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 7/18/2014; Apotex Inc. on 7/18/2014. (cla, )

2014-07-18

1

No Actions

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:14-cv-00932-LPS, 1:14-cv-00935-LPS, 1:14-cv-00941-LPS, 1:14-cv-00955-LPS (rjb)

2014-07-23

1

No Actions

DECLARATION of Mailing of Summons and Complaint on Apotex Inc. by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Noreika, Maryellen) (Entered: 07/24/2014)

2014-07-24

1

View

STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to Complaint (D.I. 1) to August 22, 2014 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 08/06/2014)

2014-08-06

1

View

SO ORDERED, re 8 STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to Complaint (D.I. 1) to August 22, 2014 filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 8/7/14. (ntl)

2014-08-07

1

No Actions

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited by Apotex Inc., Apotex Corp..(Phillips, John) (Entered: 08/22/2014)

2014-08-22

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 08/22/2014)

2014-08-22

1

View

MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Maureen L. Rurka, Samuel S. Park, Sharick Naqi, and Jason Pesick - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of James F. Hurst, # 2 Certification of Maureen L. Rurka, # 3 Certification of Samuel S. Park, # 4 Certification of Sharick Naqi, # 5 Certification of Jason Pesick)(Haney, Megan) (Entered: 09/04/2014)

2014-09-04

1

View

SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Maureen L. Rurka, Samuel S. Park, Sharick Naqi, and Jason Pesick filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 9/5/14. (ntl)

2014-09-05

1

No Actions

Pro Hac Vice Attorney Jason Pesick for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2014-09-08

1

No Actions

ANSWER to 9 Answer to Complaint, Counterclaim by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited.(Noreika, Maryellen) (Entered: 09/12/2014)

2014-09-12

1

View

Pro Hac Vice Attorney Sharick Naqi for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas)

2014-09-12

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 10/08/2014)

2014-10-08

1

View

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 10/9/14. (ntl)

2014-10-09

1

No Actions

Pro Hac Vice Attorney George C. Lombardi for Apotex Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2014-10-10

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Benjamin C. Hsing, Soumitra Deka, Jeffrey Martin, and Sylvia M. Becker - filed by Acorda Therapeutics Inc.. (Noreika, Maryellen) (Entered: 10/13/2014)

2014-10-13

1

View

Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate T. Rowe Price Associates, Inc., Other Affiliate FMR LLC, Other Affiliate Wellington Management Company, LLP for Alkermes Pharma Ireland Limited filed by Alkermes Pharma Ireland Limited. (Noreika, Maryellen) (Entered: 10/13/2014)

2014-10-13

1

View

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Benjamin C. Hsing, Soumitra Deka, Jeffrey Martin, and Sylvia M. Becker filed by Acorda Therapeutics Inc. Signed by Judge Leonard P. Stark on 10/15/14. (ntl)

2014-10-15

1

No Actions

Pro Hac Vice Attorney Jeffrey Martin for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

2014-10-21

1

No Actions

Pro Hac Vice Attorney Aaron Stiefel for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00922-LPS et al.(els)

2014-10-21

1

No Actions

Pro Hac Vice Attorney Soumitra Deka for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

2014-10-21

1

No Actions

Pro Hac Vice Attorney Daniel P. DiNapoli for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

2014-10-21

1

No Actions

NOTICE requesting Clerk to remove James F. Hurst as co-counsel. Reason for request: Attorney is no longer with Winston & Strawn LLP. (Phillips, John) (Entered: 12/22/2014)

2014-12-22

1

View

MOTION for Pro Hac Vice Appearance of Attorney Reid Smith - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Reid Smith)(Haney, Megan) (Entered: 02/09/2015)

2015-02-09

1

View

ORAL ORDER: IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposal, including a proposal for the length and timing of trial, to the Court no later than February 27, 2015. The parties are to review the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Stark, New Patent Procedures). ORDERED by Judge Leonard P. Stark on 2/10/15. Associated Cases: 1:14-cv-00882-LPS et al. (ntl) (Entered: 02/10/2015)

2015-02-10

1

View

SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney Reid Smith filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 2/11/15. (ntl)

2015-02-11

1

No Actions

Pro Hac Vice Attorney Reid Smith for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-02-12

1

No Actions

PROPOSED ORDER /Proposed Scheduling Order by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 02/27/2015)

2015-02-27

1

View

NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex Inc. (Bilson, David) (Entered: 03/13/2015)

2015-03-13

1

View

ORAL ORDER: IT IS HEREBY ORDERED that a Rule 16 scheduling teleconference has been scheduled for April 1, 2015 at 4:00 p.m. Plaintiffs' counsel shall initiate the teleconference call to 302-573-4573. No further submissions are needed. ORDERED by Judge Leonard P. Stark on 3/17/15. Associated Cases: 1:14-cv-00882-LPS et al. (ntl) (Entered: 03/17/2015)

2015-03-17

1

View

Minute Entry for proceedings held before Judge Leonard P. Stark - Scheduling Teleconference held on 4/1/2015. (Court Reporter B. Gaffigan.) Associated Cases: 1:14-cv-00882-LPS et al. (ntl)

2015-04-01

1

No Actions

Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding the parties' respective positions regarding the scheduling of Markman hearing and trial - re Scheduling Conference. (Tigan, Jeremy) (Entered: 04/08/2015)

2015-04-08

1

View

ORAL ORDER: Having reviewed the parties' letter of April 8 (C.A. No. 14-882 D.I. 26), and having had a trial slot in September 2016 open up (subsequent to the scheduling call held on April 1), IT IS HEREBY ORDERED that: (1) a five-day bench trial will begin on September 19, 2016; (2) the pretrial conference will be held on September 1, 2016 at 2:00 p.m.; (3) the proposed final pretrial order shall be submitted by August 22, 2016; (4) the Markman hearing will be held on March 7, 2016 beginning at 9:00 a.m.; (5) no motions for summary judgment will be permitted without leave of the Court; and (6) the parties shall submit a proposed scheduling order consistent with the terms of this order no later than April 20, 2015. ORDERED by Judge Leonard P. Stark on 4/13/15. Associated Cases: 1:14-cv-00882-LPS et al. (ntl) (Entered: 04/13/2015)

2015-04-13

1

View

Pro Hac Vice Attorney Samuel S. Park for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas, )

2015-04-14

1

No Actions

NOTICE OF SERVICE of Apotex Corp. and Apotex Inc.'s Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Bilson, David) (Entered: 04/15/2015)

2015-04-15

1

View

PROPOSED ORDER -- Scheduling Order -- re (25 in 1:14-cv-00932-LPS, 23 in 1:14-cv-00917-LPS, 22 in 1:14-cv-00922-LPS, 23 in 1:14-cv-00909-LPS, 53 in 1:14-cv-00935-LPS, 15 in 1:15-cv-00077-LPS, 22 in 1:14-cv-00941-LPS, 27 in 1:14-cv-00882-LPS, 23 in 1:14-cv-00955-LPS) Oral Order,,, by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Tigan, Jeremy) (Entered: 04/17/2015)

2015-04-17

1

View

Official Transcript of Telephone Conference held on April 1, 2015 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/12/2015. Redacted Transcript Deadline set for 5/22/2015. Release of Transcript Restriction set for 7/20/2015. (bpg) (Entered: 04/21/2015)

2015-04-21

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These case are CONSOLIDATED for all purposes and all papers shall be filed in Civil Action No. 14-882-LPS. Discovery due by 12/18/2015. Status Report due by 8/3/2015. Claim Construction Opening Brief due by 11/9/2015. Claim Construction Answering Brief due by 1/15/2016. A Markman Hearing is set for 3/7/2016 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Final Pretrial Conference is set for 9/1/2016 at 02:00 PM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 8/22/2016. A 5-day Bench Trial is set for 9/19/2016 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 4/21/15. Associated Cases: 1:14-cv-00882-LPS et al. (ntl) (Entered: 04/22/2015)

2015-04-22

1

View

Case associated with lead case: Create association to 1:14-cv-00882-LPS. (ntl)

2015-04-22

1

No Actions

CASE REFERRED to Magistrate Judge Burke for Mediation. Associated Cases: 1:14-cv-00882-LPS et al.(dlk)

2015-04-22

1

No Actions

Create Case Association - dkt in member case for Consol or MDL

2015-04-22

1

No Actions

ORAL ORDER: In light of the District Court's ADR referral in this case, and the number of parties involved in this matter and related cases, the Court orders as follows: Plaintiff(s) counsel shall contact counsel for each defendant to discuss whether both sides believe that the Court's assistance with settlement discussions would be helpful at some point in the case. If both plaintiff(s) and an individual defendant believe that the case has reached a stage whereby the Court's assistance is needed with regard to settlement, plaintiff(s) counsel shall contact the Court to schedule an ADR Teleconference for plaintiff and that individual defendant. Ordered by Judge Christopher J. Burke on 4/23/2015. Associated Cases: 1:14-cv-00882-LPS et al.(dlk)

2015-04-23

1

No Actions

Oral Order

2015-04-23

1

No Actions

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding denial of inter partes review. (Attachments: # 1 PTAB Decisions)(Noreika, Maryellen) (Entered: 08/27/2015)

2015-08-27

1

View

Case Referred to Mediation - Magistrate Judge only

2016-07-22

1

No Actions

PROPOSED CONSENT JUDGMENT by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Noreika, Maryellen) (Entered: 03/27/2017)

2017-03-27

1

View

SO ORDERED, re 29 CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/28/17. (ntl) (Entered: 03/29/2017)

2017-03-29

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437 B2; 8,440,703 B2; 8,663,685 B2. (etg) (Entered: 03/31/2017)

2017-03-31

1

View

Overview

Parties

Defendant

Apotex Inc. Follow

Represented By

Apotex Corp. Follow

Represented By

Plaintiff

Alkermes Pharma Ireland Limited Follow

Represented By

Acorda Therapeutics Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1556059.) - filed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. (Attachments: # 1 Exhibit A-E, # 2 Civil Cover Sheet)(cla, ) (Entered: 07/18/2014)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 07/18/2014)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/15/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 7/22/2017. (cla, ) (Entered: 07/18/2014)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437 B2; 8,440,703 B2; 8,663,685 B2;. (cla, ) (Entered: 07/18/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alkermes plc for Alkermes Pharma Ireland Limited filed by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (cla, ) (Entered: 07/18/2014)

SUMMONS Returned Executed by Alkermes Pharma Ireland Limited, Acorda Therapeutics Inc.. Apotex Corp. served on 7/18/2014, answer due 8/8/2014. (Noreika, Maryellen) (Entered: 07/18/2014)

Summons Issued with Magistrate Consent Notice attached as to Apotex Corp. on 7/18/2014; Apotex Inc. on 7/18/2014. (cla, )

Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:14-cv-00932-LPS, 1:14-cv-00935-LPS, 1:14-cv-00941-LPS, 1:14-cv-00955-LPS (rjb)

DECLARATION of Mailing of Summons and Complaint on Apotex Inc. by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Noreika, Maryellen) (Entered: 07/24/2014)

STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to Complaint (D.I. 1) to August 22, 2014 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 08/06/2014)

SO ORDERED, re 8 STIPULATION TO EXTEND TIME to Move, Answer or Otherwise Respond to Complaint (D.I. 1) to August 22, 2014 filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 8/7/14. (ntl)

ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited by Apotex Inc., Apotex Corp..(Phillips, John) (Entered: 08/22/2014)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings, Inc. for Apotex Corp., Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) (Entered: 08/22/2014)

SO ORDERED, re 11 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Maureen L. Rurka, Samuel S. Park, Sharick Naqi, and Jason Pesick filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 9/5/14. (ntl)

Pro Hac Vice Attorney Jason Pesick for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

ANSWER to 9 Answer to Complaint, Counterclaim by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited.(Noreika, Maryellen) (Entered: 09/12/2014)

Pro Hac Vice Attorney Sharick Naqi for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas)

MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) (Entered: 10/08/2014)

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney George C. Lombardi filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 10/9/14. (ntl)

Pro Hac Vice Attorney George C. Lombardi for Apotex Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Benjamin C. Hsing, Soumitra Deka, Jeffrey Martin, and Sylvia M. Becker - filed by Acorda Therapeutics Inc.. (Noreika, Maryellen) (Entered: 10/13/2014)

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Aaron Stiefel, Daniel P. DiNapoli, Benjamin C. Hsing, Soumitra Deka, Jeffrey Martin, and Sylvia M. Becker filed by Acorda Therapeutics Inc. Signed by Judge Leonard P. Stark on 10/15/14. (ntl)

Pro Hac Vice Attorney Jeffrey Martin for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

Pro Hac Vice Attorney Aaron Stiefel for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00922-LPS et al.(els)

Pro Hac Vice Attorney Soumitra Deka for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

Pro Hac Vice Attorney Daniel P. DiNapoli for Acorda Therapeutics Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:14-cv-00882-LPS et al.(els)

NOTICE requesting Clerk to remove James F. Hurst as co-counsel. Reason for request: Attorney is no longer with Winston & Strawn LLP. (Phillips, John) (Entered: 12/22/2014)

MOTION for Pro Hac Vice Appearance of Attorney Reid Smith - filed by Apotex Corp., Apotex Inc.. (Attachments: # 1 Certification of Reid Smith)(Haney, Megan) (Entered: 02/09/2015)

SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney Reid Smith filed by Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 2/11/15. (ntl)

Pro Hac Vice Attorney Reid Smith for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

PROPOSED ORDER /Proposed Scheduling Order by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Cover Letter)(Noreika, Maryellen) (Entered: 02/27/2015)

NOTICE of Appearance by David A. Bilson on behalf of Apotex Corp., Apotex Inc. (Bilson, David) (Entered: 03/13/2015)

Minute Entry for proceedings held before Judge Leonard P. Stark - Scheduling Teleconference held on 4/1/2015. (Court Reporter B. Gaffigan.) Associated Cases: 1:14-cv-00882-LPS et al. (ntl)

Letter to The Honorable Leonard P. Stark from Jeremy A. Tigan regarding the parties' respective positions regarding the scheduling of Markman hearing and trial - re Scheduling Conference. (Tigan, Jeremy) (Entered: 04/08/2015)

Pro Hac Vice Attorney Samuel S. Park for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mas, )

NOTICE OF SERVICE of Apotex Corp. and Apotex Inc.'s Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Bilson, David) (Entered: 04/15/2015)

Case associated with lead case: Create association to 1:14-cv-00882-LPS. (ntl)

CASE REFERRED to Magistrate Judge Burke for Mediation. Associated Cases: 1:14-cv-00882-LPS et al.(dlk)

Create Case Association - dkt in member case for Consol or MDL

Oral Order

Letter to The Honorable Leonard P. Stark from Maryellen Noreika regarding denial of inter partes review. (Attachments: # 1 PTAB Decisions)(Noreika, Maryellen) (Entered: 08/27/2015)

Case Referred to Mediation - Magistrate Judge only

PROPOSED CONSENT JUDGMENT by Acorda Therapeutics Inc., Alkermes Pharma Ireland Limited. (Noreika, Maryellen) (Entered: 03/27/2017)

SO ORDERED, re 29 CONSENT JUDGMENT, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 3/28/17. (ntl) (Entered: 03/29/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,540,938; 8,007,826 B2; 8,354,437 B2; 8,440,703 B2; 8,663,685 B2. (etg) (Entered: 03/31/2017)

Track Case Updates

Apotex Inc.

Apotex Corp.

Alkermes Pharma Ireland Limited

Acorda Therapeutics Inc.